NCT02663284View on ClinicalTrials.gov

Evaluation of the Physiodoloris Pain Monitor in Patients With Complex Regional Pain Syndrome

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Complex Regional Pain Syndrome
Interventions
DRUG

Ropivacaine 0.5%

Ropivacaine is used to performed the perineural block

Trial Locations (1)

62231

Clinique des 2 Caps, Coquelles

All Listed Sponsors
lead

Hopital Foch

OTHER

NCT02663284 - Evaluation of the Physiodoloris Pain Monitor in Patients With Complex Regional Pain Syndrome | Biotech Hunter | Biotech Hunter